Pure Global AI
Applicant profile

Sauflon Pharmaceuticals Ltd.

Sauflon Pharmaceuticals Ltd.
Hong Kong MDACSUnited Kingdom8 registered devicesJul 07, 2015 – Aug 10, 2015
VerifiedMDD (Medical Device Division) · MDACS registry
8
Total devices
2
Risk classes
2015
First registration
2015
Most recent
Applicant overview
Applicant (EN)
Sauflon Pharmaceuticals Ltd.
Applicant (ZH)
Sauflon Pharmaceuticals Ltd.
Country
United Kingdom
英国
Address
49-53 York Street, Twickenham, UK.
英国特威克纳姆约克街49-53号.
Timeline
First registration
Jul 07, 2015
Most recent
Aug 10, 2015
Regulatory footprint
Search Sauflon Pharmaceuticals Ltd. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk class breakdown
II5
III3
Recent MDACS registrations
Latest 15 devices linked to this applicant
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Aug 10, 2015
Risk class
II
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Aug 10, 2015
Risk class
II
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Aug 10, 2015
Risk class
II
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Aug 05, 2015
Risk class
II
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Aug 05, 2015
Risk class
II
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Washer/ Decontamination Units, Contact Lens
清洗机/去污装置,隐形眼镜
Jul 07, 2015
Risk class
III
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Cleaning Solutions, Contact Lens
清洁溶液,隐形眼镜
Jul 07, 2015
Risk class
III
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
Cleaning Solutions, Contact Lens
清洁溶液,隐形眼镜
Jul 07, 2015
Risk class
III
Authorised rep
Coopervision Hong Kong Limited酷柏光学(香港)有限公司
About this profile

Sauflon Pharmaceuticals Ltd. is associated with 8 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.